Dalfampridine
Ended Awarded
- Contract number
- VA77017J0306
- Awardee
-
Acorda Therapeutics, Inc. UEI R5D3FUPFFPK4
- Awarding agency
-
Veterans Integrated Service Network 15
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $478,860
Award facts
- Contract value 100% obligated
- $478,860.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- Veterans Integrated Service Network 12 Veterans Health Administration, Department of Veterans Affairs
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Ardsley, NY 10502, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Department of Veterans Affairs (VA) awarded a firm fixed-price delivery order contract to Acorda Therapeutics, Inc., a biotechnology company specializing in therapies for neurological disorders. The contract, valued at $478,860.00, is for the supply of DALFAMPRIDINE, a medication used to treat Parkinson's disease and multiple sclerosis. The delivery order was placed under Acorda's existing Federal Supply Schedule (FSS) contract with the VA (36F79723D0194), valued at over $16.3 million, which covers the supply of drugs, pharmaceuticals, and hematology-related products. Additionally, Acorda holds two Blanket Purchase Agreements (BPAs) with the VA National Acquisition Center, valued at $5.5 million and $7.5 million, specifically for the procurement of Inbrija and Ampyra, the company's neurological medications. This contract does not have a set-aside designation, indicating that Acorda competed on an unrestricted basis. The contract will support the VA's mission to provide quality healthcare to veterans suffering from neurological conditions.
Quick answers
Who was awarded contract VA77017J0306?
VA77017J0306 was awarded to Acorda Therapeutics, Inc. by Veterans Integrated Service Network 15 (Veterans Health Administration) on December 13, 2016.
How much is contract VA77017J0306 worth?
The government has obligated $478,860 on VA77017J0306.
Which agency awarded contract VA77017J0306?
Veterans Integrated Service Network 15 (Veterans Health Administration) awarded VA77017J0306, with funding from Veterans Integrated Service Network 12 (Veterans Health Administration).
Is contract VA77017J0306 an order under another contract?
Yes. VA77017J0306 is a delivery order under V797P5233B, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract VA77017J0306 competed?
The extent of competition for VA77017J0306 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award